» Articles » PMID: 1137829

Prophylaxis of Recurring Urinary Tract Infection in Females: a Comparison of Nitrofurantoin with Trimethoprim-sulfamethoxazole

Overview
Journal Can Med Assoc J
Specialty General Medicine
Date 1975 Jun 14
PMID 1137829
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Twenty-eight females with recurrent urinary tract infection were treated to eradicate their existing infections and then observed for recurrences while receiving one of the three following prophylactic regimens for 6 to 12 months: nitrofurantoin, 50 mg daily; one half tablet of trimethoprim-sulfamethoxazole (TMP-SMX) twice weekly; or one tablet of TMP-SMX once weekly. Preadolescent girls received half the adult doses. After completion of the course of prophylactic agent the patients were followed up at bimonthly intervals until infection recurred. After eradication of this new infection they were started on another prophylactic regimen. Six infections (1.0/patient-year) recurred in patients on nitrofurantoin, four infections (0.4/patients-year) reucrred in those receiving twice weekly TMP-SMX, and 12 infections (1.3/patient-year) in those receiving once weekly TMP-SMX. The mean interval between discontinuation of prophylaxis and recurrence of infection was 2.6 months. TMP-SMX in the doses used eliminated aerobic gram-negative rods from swabs from the anal canal in many patients. Gram-negative organisms resistant to trimethoprim did not cause infection either during or after therapy.

Citing Articles

Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.

DE Vita D, Giordano S Int Urogynecol J. 2012; 23(12):1707-13.

PMID: 22614285 DOI: 10.1007/s00192-012-1794-z.


Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.

Albert X, Huertas I, Pereiro I, Sanfelix J, Gosalbes V, Perrota C Cochrane Database Syst Rev. 2004; (3):CD001209.

PMID: 15266443 PMC: 7032641. DOI: 10.1002/14651858.CD001209.pub2.


Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Patel R, Welling P Clin Pharmacokinet. 1980; 5(5):405-23.

PMID: 7408366 DOI: 10.2165/00003088-198005050-00001.


Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Wormser G, Keusch G, Heel R Drugs. 1982; 24(6):459-518.

PMID: 6759092 DOI: 10.2165/00003495-198224060-00002.


Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.

Haase D, Harding G, Thomson M, Kennedy J, Urias B, Ronald A Antimicrob Agents Chemother. 1984; 26(4):481-4.

PMID: 6240223 PMC: 179948. DOI: 10.1128/AAC.26.4.481.


References
1.
Turck M, Ronald A, Petersdorf R . Susceptibility of Enterobacteriaceae to nitrofurantoin correlated with eradication of bacteriuria. Antimicrob Agents Chemother (Bethesda). 1966; 6:446-52. View

2.
Bailey R, Roberts A, Gower P, DE WARDENER H . Prevention of urinary-tract infection with low-dose nitrofurantoin. Lancet. 1971; 2(7734):1112-4. DOI: 10.1016/s0140-6736(71)91270-0. View

3.
Harding G, Ronald A . A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med. 1974; 291(12):597-601. DOI: 10.1056/NEJM197409192911203. View

4.
Moorhouse E, Farrell W . Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains. J Med Microbiol. 1973; 6(2):249-52. DOI: 10.1099/00222615-6-2-249. View

5.
Winberg J, Bergstrom T, Lincoln K . Treatment trials in urinary tract infection (UTI) with special reference to the effect of antimicrobials on the fecal and periurethral flora. Clin Nephrol. 1973; 1(3):142-8. View